Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
NEI Podcast - E157 - (CME) Wide Awake: An Update on Best Practices for the Treatment and Management of Insomnia

E157 - (CME) Wide Awake: An Update on Best Practices for the Treatment and Management of Insomnia

08/31/22 • 58 min

1 Listener

NEI Podcast

In this episode, Dr. Andrew Cutler interviews Dr. Karl Doghramji on best practices for the treatment and management of insomnia.

Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD22-Sleep

Learning Objectives: After completing this educational activity, you should be better able to:

  • Utilize assessment tools in the diagnosis of insomnia
  • Address challenges in the pharmacologic treatment of insomnia
  • Implement evidence-based pharmacological treatments for insomnia

Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A posttest score of 70% or higher is required to receive CME/CE credit. The content in this activity pertains to pharmacology and is worth 1.0 continuing education hour of pharmacotherapeutics.

Credit Types. The following are being offered for this activity:

  • Nurse Practitioner: ANCC contact hours
  • Pharmacy: ACPE application-based contact hours
  • Physician: ACCME AMA PRA Category 1 Credits TM
  • Physician Assistant: AAPA Category 1 CME credits
  • Psychology: APA CE credits
  • Social Work: ASWB-ACE CE credits
  • Non-Physician Member of the Healthcare Team: Certificate of Participation stating the program is designated for AMA PRA Category 1 Credits TM

Peer Review: The content was peer-reviewed by an MD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity.

Disclosures: All individuals in a position to influence or control content were required to disclose all relevant financial relationships. Any potential conflicts of interest were identified and mitigated prior to the activity being planned, developed, or presented.

I nterviewerAndrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Carlsbad, CAConsultant/Advisor: AbbVie, Acadia, AiCure, Alfasigma, Alkermes, Allergan, Atentiv, Cognitive Research, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sage, Sunovion, Supernus, Takeda, Teva Speakers Bureau: AbbVie, Acadia, Alkermes, Allergan, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Teva, Tris

IntervieweeKarl Doghramji, MDProfessor, Department of Psychiatry & Human Behavior; Associate Professor, Departments of Neurology and of Medicine; Medical Director, Jefferson Sleep Disorders Center; Program Director, Fellowship in Sleep Medicine; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PAResearch/Grant: Harmony, Inspire Consultant/Advisor: Axsome, Eisai, Jazz, Harmony, Idorsia, Imbrium, Inspire Stockholder: Merck

Pre-Interview AuthorSabrina K. Bradbury-Segal, PhDMedical Writer, Neuroscience Education Institute, Carlsbad, CANo financial relationships to disclose.

The Planning Committee and Peer Reviewer have no financial relationships to disclose.

Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.

Cultural Linguistic Competencies and Implicit Bias: A variety of resources addressing cultural and linguistic competency, and strategies for understanding and reducing implicit bias can be found in this handout.

Support: This activity is supported by an unrestricted educational grant from Eisai.

Released: August 31, 2022 CE credit expires: August 31, 2025

plus icon
bookmark

In this episode, Dr. Andrew Cutler interviews Dr. Karl Doghramji on best practices for the treatment and management of insomnia.

Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD22-Sleep

Learning Objectives: After completing this educational activity, you should be better able to:

  • Utilize assessment tools in the diagnosis of insomnia
  • Address challenges in the pharmacologic treatment of insomnia
  • Implement evidence-based pharmacological treatments for insomnia

Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A posttest score of 70% or higher is required to receive CME/CE credit. The content in this activity pertains to pharmacology and is worth 1.0 continuing education hour of pharmacotherapeutics.

Credit Types. The following are being offered for this activity:

  • Nurse Practitioner: ANCC contact hours
  • Pharmacy: ACPE application-based contact hours
  • Physician: ACCME AMA PRA Category 1 Credits TM
  • Physician Assistant: AAPA Category 1 CME credits
  • Psychology: APA CE credits
  • Social Work: ASWB-ACE CE credits
  • Non-Physician Member of the Healthcare Team: Certificate of Participation stating the program is designated for AMA PRA Category 1 Credits TM

Peer Review: The content was peer-reviewed by an MD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity.

Disclosures: All individuals in a position to influence or control content were required to disclose all relevant financial relationships. Any potential conflicts of interest were identified and mitigated prior to the activity being planned, developed, or presented.

I nterviewerAndrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Carlsbad, CAConsultant/Advisor: AbbVie, Acadia, AiCure, Alfasigma, Alkermes, Allergan, Atentiv, Cognitive Research, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sage, Sunovion, Supernus, Takeda, Teva Speakers Bureau: AbbVie, Acadia, Alkermes, Allergan, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Teva, Tris

IntervieweeKarl Doghramji, MDProfessor, Department of Psychiatry & Human Behavior; Associate Professor, Departments of Neurology and of Medicine; Medical Director, Jefferson Sleep Disorders Center; Program Director, Fellowship in Sleep Medicine; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PAResearch/Grant: Harmony, Inspire Consultant/Advisor: Axsome, Eisai, Jazz, Harmony, Idorsia, Imbrium, Inspire Stockholder: Merck

Pre-Interview AuthorSabrina K. Bradbury-Segal, PhDMedical Writer, Neuroscience Education Institute, Carlsbad, CANo financial relationships to disclose.

The Planning Committee and Peer Reviewer have no financial relationships to disclose.

Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.

Cultural Linguistic Competencies and Implicit Bias: A variety of resources addressing cultural and linguistic competency, and strategies for understanding and reducing implicit bias can be found in this handout.

Support: This activity is supported by an unrestricted educational grant from Eisai.

Released: August 31, 2022 CE credit expires: August 31, 2025

Previous Episode

undefined - E156 - The PsychopharmaStahlogy Show: The Antisocial Personality Disorder Spectrum: Diagnosis and Treatment

E156 - The PsychopharmaStahlogy Show: The Antisocial Personality Disorder Spectrum: Diagnosis and Treatment

What is the difference between psychopathy and antisocial personality? What is known about gender differences when it comes to antisocial personality disorder?

In this episode, Dr. Andrew Cutler interviews Dr. James Knoll about how to diagnose and treat antisocial personality disorder.

With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on decriminalizing mental illness.

Episodes to be released under this theme include:

Part 1: Decriminalizing Mental Illness with Dr. Katherine Warburton

Part 2: The Antisocial Personality Disorder Spectrum: Diagnosis and Treatment with Dr. James Knoll

Part 3: Intensive Level Care for Violent Patients with Serious Mental Illness with Dr. Carolina Klein

Subscribe to the NEI Podcast, so that you don’t miss another episode!

Next Episode

undefined - E158 - September is the American Medical Association (AMA)’s Women in Medicine Month

E158 - September is the American Medical Association (AMA)’s Women in Medicine Month

In this episode, we take a look back at some of the incredible women in medicine we’ve had on the NEI Podcast over the years. We begin with reflecting on Episode 69: A Beacon of Hope in the Storm of Mental Illness: An Update on Suicide Awareness and Prevention with Dr. Christine Moutier. Dr. Moutier is the Chief Medical Officer of the American Foundation for Suicide Prevention. To hear the full episode click on the link below:

https://neiglobal.libsyn.com/a-beacon-of-hope-in-the-storm-of-mental-illness-an-update-on-suicide-awareness-and-prevention-with-dr-christine-moutier

Next, we turn to Episode 77: Mental Health in the Muslim Community with Dr. Mona Masood. Dr Masood is a psychiatrist and she is on the Board of Directors at the Muslim Wellness Foundation. To listen to the full episode click on the link below:

https://neiglobal.libsyn.com/e77-mental-health-in-the-muslim-community-with-dr-mona-masood

We then return to our interview with Dr. Christina Girgis in Episode 79: Gender Disparities in the Mental Health Profession with Dr. Christina Girgis. Dr. Girgis is certified by both the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine. She is currently the Medical Director of the Consultation-Liaison Psychiatry Service at Edward Hines, Jr. VA Hospital and the Associate Training Director of the Psychiatry Residency Program at Loyola University Medical Center. To hear the complete episode click on the link below:

https://neiglobal.libsyn.com/e79-gender-disparities-in-the-mental-health-profession-with-dr-christina-girgis

Next, we reflect on Episode 82: Refreshing Perspectives on Recovery: September is National Recovery Month with Dr. Nzinga Harrison. Dr. Harrison is Board-Certified in both Adult General Psychiatry and Addiction Medicine and she is the Chief Medical Officer and Co-founder of Eleanor Health. To hear the full episode, click on the link below:

https://neiglobal.libsyn.com/e82

We then turn to Episode 101: Ooh Child, Things are Going to Get Easier: Managing Pediatric Anxiety with Dr. Krystal Lewis. Dr. Lewis is clinical psychologist with the Section on Development and Affective Neuroscience (SDAN) at the National Institute of Mental Health (NIMH). She is also a member of the Stigma Scientific Interest Group (SIG), and the NIMH Anti-Racism Task Force at the National Institute of Health (NIH). For the complete episode, click on the link below:

https://neiglobal.libsyn.com/e101-ooh-child-things-are-going-to-get-easier-managing-pediatric-anxiety-with-dr-krystal-lewis

Finally, we reflect on Episode 150: Blazing Trails to Breakdown Structural Racism and Improve Black Mental Health with Dr. Sarah Vinson. She is triple-board certified in adult, child & adolescent, and forensic psychiatry and the founder of the Lorio Psych Group. To listen to the complete episode, click on the link below:

https://neiglobal.libsyn.com/blazing-trails-to-breakdown-structural-racism-and-improve-black-mental-health

We hope you’ve enjoyed a look back at some of the most amazing women in medicine we’ve had on our show!

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/nei-podcast-25360/e157-cme-wide-awake-an-update-on-best-practices-for-the-treatment-and-23395050"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to e157 - (cme) wide awake: an update on best practices for the treatment and management of insomnia on goodpods" style="width: 225px" /> </a>

Copy